Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study
Contributeurs/tricesBucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; Telenti, A.; Hirschel, Bernard; Weber, R.; Bernasconi, Enos; Vernazza, P.; Minder, C.; Battegay, M.
Publié dansHIV medicine, vol. 3, no. 4, p. 247-253
Date de publication2002
Résumé
Mots-clés
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- CD4 Lymphocyte Count
- Cohort Studies
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- HIV Infections/ drug therapy
- HIV Protease Inhibitors/ administration & dosage
- Humans
- Male
- Middle Aged
- Prospective Studies
- RNA, Viral/blood
- Reverse Transcriptase Inhibitors/ administration & dosage
- Ritonavir/ administration & dosage
- Saquinavir/ administration & dosage
- Viral Load
Structure d'affiliation
Citation (format ISO)
BUCHER, H. C. et al. Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study. In: HIV medicine, 2002, vol. 3, n° 4, p. 247–253. doi: 10.1046/j.1468-1293.2002.00113.x
Fichiers principaux (1)
Article
Identifiants
- PID : unige:7124
- DOI : 10.1046/j.1468-1293.2002.00113.x
- PMID : 12444942
ISSN du journal1464-2662